Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING
Marine Bruand(Swiss Cancer Center Léman), George Coukos(Ludwig Cancer Research)
Cited by 134
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Deciphering and Reversing Tumor Immune Suppression
|Immunity|2013|597
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
|Frontiers in Immunology|2019|423
Targeting the tumor vasculature to enhance T cell activity
|Current Opinion in Immunology|2015|330